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Abstract
The state of health of patients is typically not characterized by a single disease
alone but by multiple (comorbid) medical conditions. These comorbidities may
depend strongly on age and gender. We propose a speciﬁc phenomenological
comorbidity network of human diseases that is based on medical claims data of
the entire population of Austria. The network is constructed from a two-layer
multiplex network, where in one layer the links represent the conditional
probability for a comorbidity, and in the other the links contain the respective
statistical signiﬁcance. We show that the network undergoes dramatic structural
changes across the lifetime of patients. Disease networks for children consist of a
single, strongly interconnected cluster. During adolescence and adulthood fur-
ther disease clusters emerge that are related to speciﬁc classes of diseases, such
as circulatory, mental, or genitourinary disorders. For people over 65 these
clusters start to merge, and highly connected hubs dominate the network. These
hubs are related to hypertension, chronic ischemic heart diseases, and chronic
obstructive pulmonary diseases. We introduce a simple diffusion model to
understand the spreading of diseases on the disease network at the population
level. For the ﬁrst time we are able to show that patients predominantly develop
diseases that are in close network proximity to disorders that they already suffer.
The model explains more than 85% of the variance of all disease incidents in the
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population. The presented methodology could be of importance for anticipating
age-dependent disease proﬁles for entire populations, and for design and vali-
dation of prevention strategies.
S Online supplementary data available from stacks.iop.org/njp/16/115013/
mmedia
Keywords: network medicine, disease dynamics, multilayer statistics, medical
claims data
1. Introduction
Diseases are usually deﬁned by a set of phenotypes that are associated with various
pathobiological processes and their mutual interactions. Recently, there has been impressive
progress in the understanding of various types of relations between disease phenotypes on the
basis of common underlying molecular processes [1]. For example, two diseases can be related
if there are genes that are associated to both of them [2–5]. It was shown that genes associated
with the same disorder encode proteins that have a strong tendency to interact with each other
[2]. Alternatively, one can think of two diseases being linked and related if their metabolic
reactions within a cell share common enzymes [6]. Networks of protein–protein interactions
[7, 8] have also been studied in the context of disease interactions [9, 10]. Such interaction
networks for seemingly unrelated gene products were shown to be involved in a group of
different diseases that share clinical and pathological phenotypes [10].
The large number of relations between myriads of cellular components implies that
diseases are not a clearcut concept, but merely act as some sort of a ‘discretization’ in a vast and
complicated phenotype space [1]. The structure of this space is typically studied through
phenotypic comorbidity relations between human diseases. A comorbidity relation means that
two diseases occur more frequently within a patient than what would be expected from the
frequency of the individual diseases alone. This means that the joint probability for suffering
two diseases i and j together is larger than the product of the probabilities of the individual
diseases (prevalences), >P i j P i P j( , ) ( ) ( ). A phenotypic human disease network (PHDN)
consists of nodes representing the diseases and links that indicate comorbidity relations [11].
PHDNs have opened a novel way for doing medicine on a population-wide scale. For example
it has been shown that there exist pronounced ethnic differences in the PHDNs of black and
white males [11], and that PHDNs may be used to predict future sites of cancer metastasis [12].
Note that only a limited number of comorbidities can be explained by common genes, proteins,
or metabolites [4, 13]. These differences with respect to the clinical reality of disease not only
reﬂect our limited knowledge of cellular processes, they also underscore the role of
environmental and epigenetic factors in disease progression. Another class of highly relevant
networks in medicine are physiological networks that describe interactions of organ systems in
the human organism [14, 15]. Changes in physiological function can be understood as
topological transitions of such physiological networks [14, 15].
The age-dependence of PHDNs is hitherto unknown. Up to now, studies on US Medicare
data have uncovered comorbidity relations in patients aged 65 and older [11, 13]. In this work
we use a complete medical claims data set that contains information on all of the 8.3 million
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Austrians who received medical treatments in the years 2006 and 2007. The data set has been
studied before to show a strong relationship between hunger in early life and the development
of metabolic diseases in later life [16, 17]. Further, the nationwide age and gender dependence
of diabetic complications was studied on the same data set [18].
For the ﬁrst time, here we obtain a speciﬁc age-dependent PHDN of all statistically
signiﬁcant comorbidity relations that pose a substantial risk to male or female patients. We do
so by proposing a new statistical method that leads to an age- and genderspeciﬁc disease–
disease network. This network is obtained by combining the layers of a disease–disease
multiplex network that consists of two layers that encode different phenomenological statistical
measures for disease–disease relations. In the ﬁrst layer links quantify the statistical signiﬁcance
of a comorbidity relation between two diseases through their correlation coefﬁcient for binary
data. The technical challenge here is that the prevalences of individual diseases can vary over
several orders of magnitude, from affecting a few dozens to ten thousands of patients in the
database [11]. This variability leads to biases in the correlations [19]. In particular, correlations
between highly frequent and rare diseases tend to be underestimated [11, 19]. We therefore
employ a multi-scale correction that accounts for this bias [20]. Links between nodes i and j in
the second layer represent the risk of obtaining disease i, given that the patient already suffers
from disease j. The ﬁrst layer encodes information whether there exists a signiﬁcant relation
between two diseases; the second layer quantiﬁes the risk that a disease relation poses to the
patient.
We quantify the topological network properties of the so-obtained PHDN and show that
they undergo massive structural and gender-speciﬁc changes across lifetime. We show that this
analysis allows us to understand the progression of the health state of a population on a new
level. Various stages of life are characterized by a unique combination of tightly interrelated
disease clusters. With changing patient age, these clusters of diseases emerge, vanish, merge, or
form local hubs. To a certain degree the concept of individual diseases becomes meaningless;
what determines disease risks and the health state of a population more effectively is the
strongly age-dependent mesoscopic organization of the PHDN in disease clusters.
Finally, we develop a simple network diffusion model for the population-wide dynamics
of disease progressions. The model is based on the empirical age- and gender-speciﬁc
comorbidity relations recorded in the PHDN. In particular, we show that using (i) the
prevalence of all diseases within a speciﬁc age group and (ii) the age-dependent network
structure of diseases for a given age, we can explain more than 85% of the variance of the
appearances of new diseases within the next eight years in the total population. These results
might provide important information for estimating the future burden of diseases in an aging
society. The fraction of the EU population aged 65 or older will almost double by the year 2060
to 29.6% of the population, from 17.5% in 2011. The average age of the EU-27 citizen is
estimated to be 47.6 years, compared to 41.2 years in 2011 [21]. However, quality of life is not
determined by mere life expectancy per se, but by the number of years that are spent in healthy
conditions. Healthy-life years differ greatly between men and women and across member states
of the EU. Whereas life expectancy for women is 6.4y higher than for men, the number of
healthy-life years for women is only 1.2y higher [22]. Aging of the population has severe
implications for economic growth. Estimates suggest that by 2030 the EU-27 will experience a
14% decrease in workforce and a 7% decrease in consumer population due to aging [23]. It is
therefore one of the big societal challenges to understand and anticipate to what extent the aging
of the population will affect the future health state of a population.
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2. Data and methods
2.1. Data
We use a database of the Main Association of Austrian Social Security Institutions that contains
pseudonymized claims data of all persons receiving outpatient and inpatient care in Austria
between 1 January 2006 and 31 December 2007. The data provides a comprehensive,
nationwide collection of the medical condition of the vast majority of Austriaʼs population of
8.3 million people. Information on diagnoses is available for all persons receiving inpatient
care, so-called inpatients. The total sample of inpatients consists of 1,862,258 patients
(1,064,952 females and 797,306 males) and includes their year of birth, gender, date of death,
their drug prescriptions, and main- and side-diagnoses. Patients are grouped according to their
age. The age groups, labeled by a, contain all patients whose age is between a and +a 8 years.
Diagnosis are provided in the 10th revision of the International Statistical Classiﬁcation of
Diseases and Related Health Problems (ICD 10) [24], a medical classiﬁcation list by the World
Health Organization (WHO). Not all ICD codes represent disorders—they may also indicate
general examinations, injuries, pregnancies, or collections of symptoms that could be indicative
of a large number of diseases. We exclude these categories and work with the D = 1,055
diagnoses on the three-digit ICD levels in chapters A–N. We will use the words disease,
disorder, and diagnosis interchangeably whenever referring to a speciﬁc ICD entry. It was
found that such data can generally be considered to be complete with only a small amount of
gross diagnostic miscoding [25]. Prognostic models for hospitalizations built on comorbidity
scores derived from medical claims data perform similarly well as survey-derived data [26].
2.2. Derivation of the disease network from a statistical multiplex network
We use the following notation. In our data we have N a( )m f men/women in age group a. Let us
consider index pairs, where index i indicates patients suffering disease i and ¬i indicates
patients not having the diagnosis i. Each of the N a( )m f patients belongs to one of four index
pairs, ¬ ¬ ¬ ¬i j i j i j i j{( , ), ( , ), ( , ), ( , )}, meaning that the patient has diseases i and j, has j but
not i, has i but not j, or has neither i nor j, respectively. The numbers
¬ ¬ ¬ ¬N a N a N a N a( ), ( ), ( ), ( )i j
m f
i j
m f
i j
m f
i j
m f
, , , , denote the number of male/female patients in age group
a in these respective groups. The prevalence for each disease i is deﬁned as =p a( )im f
N a
N a
( )
( )
i
m f
m f
.
In the following, we sometimes suppress the indices for age and gender for clarity.
2.2.1. Layer 1: statistical significance of comorbidity relations. The ﬁrst layer of the PHDN
multiplex provides the statistical signiﬁcance of relations between any two diseases i and j.
With the above notation the contingency coefﬁcient ϕij for a speciﬁc age group is deﬁned by
ϕ =
−¬ ¬ ¬ ¬
¬ ¬
N N N N
N N N N
. (1)ij
i j i j i j i j
i i j j
, , , ,
A value of ϕ a( )ij is computed for the patient numbers in each age group a. These values are
directly related to the chi-square-coefﬁcient χ ϕ=a N a( ) ( ) ( )( )ij ij a2 ( ) 2, where N(a) is the number
of patients in the considered age group. A chi-square test can be used to reject the null
hypothesis for a given conﬁdence level that the occurrence of disease i is independent of the
4
New J. Phys. 16 (2014) 115013 A Chmiel et al
occurrence of disease j in the same patient. ϕ ϕ= ( )ij is a symmetric matrix containing the test
statistics for diseases i and j. We discard negative entries by setting ϕ → 0ij , whenever ϕ < 0.ij
For later use we deﬁne an unweighted adjacency matrix J derived from ϕ by deﬁning =J 1ij if
ϕ > 0,ij and =J 0ij otherwise.
There are known biases in the test statistic ϕij that depend on the prevalences p a( )im f and
p a( )j
m f of the diseases i and j. While the contingency coefﬁcient is a reliable measure for
correlations whenever diseases i and j have similar prevalences p a( )i
m f and p a( )j
m f , ϕ
underestimates correlations between very rare and highly frequent diseases [11, 19]. It is
therefore unclear if low values for ϕij for two diseases i and j imply weak correlations or large
differences in their respective prevalences.
Assume that disease i has a very low prevalence p a( )i
m f with respect to the prevalence
values of the majority of other diseases. Then each of its ϕ-values can be assumed to
underestimate the true correlations, with respect to similar ϕ-values obtained from more
frequent diseases. A simple way to correct these biases is to compare values of ϕij for disease i
with the typical correlation strength for disease i [20]. To this end, consider the matrix
ϕ
ϕ
ϕ
= , (2)ij
ij
i
where ϕ〈 〉 = ϕ∑
∑
=
=
i
J
j
D
ij
j
D
ij
1
1
. While ϕ is an undirected network, ϕ∼ is typically directed. To obtain a
unique and bias-corrected measure for the strength of the correlation between diseases i and j,
an undirected version ϕ* of the network ϕij is obtained by ϕ ϕ ϕ=  { }max ,ij ij ji* .
2.2.2. Layer 2: conditional disease risk. The second layer of the PHDN multiplex is given by
the risk for a patient of a certain age group and gender to have disease i, given that she has
disease j. The conditional probability P i j( | ) for a patient who suffers disease j to also suffer
disease i is given by =P i j( | ) N
N
i j
j
, . A thresholded, undirected, and unweighted version P* of
P i j( | ) is
⎪
⎧
⎨
⎩=
>{ }P P P p1 max ,
0 otherwise
, (3)ij
ij ji c*
for a given threshold >p 0c .
2.2.3. Overlap of the multiplex network layers. The overlap (intersection) of the two multiplex
network layers, ϕ* and P*, the network O, is given by
⎪
⎧⎨
⎩
ϕ ϕ= > >O P p1 if and
0 otherwise
. (4)i j ij c
ij c
,
* *
The network Oij links two diseases i and j if the link weights in both network layers exceed
given thresholds—namely, ϕc for the statistical signiﬁcance layer Φ*, and pc for the conditional
risk layer P*. Note that up to ﬁrst order of
∑ = J
1
j
D
ij1
the thresholding of the statistical signiﬁcance
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layer ϕ* by the value ϕc, as done in equation (4), yields the same results as the application of the
multiscale ﬁlter proposed in [20]. From now on we refer to Oij simply as the ‘disease network.’
It is a variant of a PHDN. In contrast to the PHDN studied in [11], the disease network Oij is
built around a combination of measures (conditional probabilities and contingency coefﬁcients)
that have been corrected for biases that result from the comparison of very rare and frequent
diseases.
3. Results
3.1. Progression of diseases with aging
Let da be the number of diseases diagnosed in patients with a hospital stay of at least one day in
a given age group during the two years 2006 and 2007. Figure 1 shows the cumulative
distribution functions (cdf) for the numbers of diseases da for three different age groups,
a = 10–20 years, a = 50–60 years, and >a 80 years, for males and females. The cdf for all age
groups are presented in supplementary information (SI) ﬁgures 1 and 2. In the ﬁrst age group
the distribution suggests an approximate power-law behavior up to about 20 diseases. With
increasing age the disease distributions takes on a more exponential character. The average
number of diseases per patient in each age group, 〈 〉da , is shown in the inset of ﬁgure 1.
Children in the ﬁrst age group have a higher average number of diagnoses than teenagers. After
adolescence there is a continuous increase in the number of diseases per patient in the
population, from two (at the age of around 20) to more than ﬁve for patients older than 80. Men
between 30 and 70 have generally more diseases then women, which reverses at older ages. The
number of diagnoses for females around 20 is higher than those for males.
Figure 1. Cumulative distributions of the number of diagnoses for a typical inpatient for
three age groups =a 10–20 years, 50–60 years, and >a 80 years are shown. In the ﬁrst
age group the disease distributions follow an approximate power-law. In older ages the
distributions look more exponential. The inset shows the average number of diagnoses
〈 〉da for inpatients for women (red squares) and men (blue circles). Standard deviations
of da are smaller than the symbol size.
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3.2. Network properties of the disease network
The large increase in diagnoses per patient over age is related to substantial topological changes
of the ϕ* and P* networks. Network properties for the two layers are shown in ﬁgure 2. The
number of nodes N (ﬁgure 2(A)), the average degrees 〈 〉k (ﬁgure 2(B)), and the average nearest
neighbour degrees 〈 〉k nn (ﬁgure 2(D)), increase with age in both layers. For patients aged above
65 the degrees are larger for women than for men. The clustering coefﬁcients C for each
network are given in units of the clustering as expected from a random graph, Cr, in ﬁgure 2(C).
C Cr is larger for ϕ than for the conditional risk layer for all age groups except for the youngest
children. This ratio shows a clear maximum around age 25 in the ϕ* layer, but it decreases
monotonically in the P* layer. Correlation coefﬁcients between the degree sequences of ϕ* and
P* are given for two choices of thresholds in the SI; see table S1. In one case we set the
thresholds in the ϕ* and P* layers to pc = 0.01 and ϕ = 2c , respectively, and in the other case the
thresholds are both zero, ϕ= =p 0c c . We ﬁnd higher degree correlations across the two layers
for the non-zero threshold values, compared to the case where the thresholds are both zero. This
suggests that the thresholding tends to ﬁlter out links that appear in only one of the layers. With
increasing patient age, the difference between the degree correlations also increases.
Network properties for the disease network O for the threshold values ϕ = 2c and pc = 0.01
are shown in ﬁgure 3. The numbers of nodes N (ﬁgure 3(A)), average degrees 〈 〉k (ﬁgure 3(B)),
and the ratios of clustering coefﬁcients C Cr (ﬁgure 3(C)), show a similar behavior with
increasing age. They decrease from the ﬁrst to second age group, and increase until about age
50. For higher ages the increase levels off and the network measures decrease again. The
Figure 2. Basic network properties for the two levels P* and ϕ* of the multiplex are
compared across age. Results for the conditional risk layer are shown in circles for
females (red) and males (blue). For the statistical signiﬁcance layer ϕ* results are shown
for females (green) and males (black) in squares. (A) The number of nodes N with at
least one link increases in both network layers from childhood into adulthood and levels
off at higher ages. (B) Average degrees 〈 〉k increase over age. (C) Values of the
clustering coefﬁcients C divided by Cr (clustering coefﬁcient for corresponding random
graph) show a pronounced peak around age 25 for the ϕ* network, and a consistent
decrease in clustering for P*. (D) Average degrees of nearest neighbors 〈 〉k nn increase
with age. Error bars show the standard deviations.
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average nearest neighbour degrees do not level off at high ages but continue to increase; see
ﬁgure 3(D). The disease network is most dense for both males and females for the age range
48–56. Results for the modularities of ϕ*, P*, and O as a function of patient age and gender are
shown in the SI; see ﬁgure S6. The disease network O has typically higher modularities than the
layers ϕ* and P*, which suggests that disease clusters can be easier identiﬁed in O than in its
individual layers. We conﬁrmed that the network properties shown in ﬁgure 3 are to a large
extend independent from the actual choices of the threshold values pc and ϕc; see SI
ﬁgures S7–10.
Visualizations of the disease networks O across lifetime are presented in ﬁgure 4 for males
and females. Massive structural reorganization in the disease networks are clearly visible across
age. Nodes represent diseases i; their size is proportional to the disease prevalence, N a( )i
m f .
The diseases type, as represented by the ﬁrst letters from the ICD 10 code, is indicated by node
colors. Link colors are identical to the node colors if both diseases share the same type;
otherwise, it is a mix of the two colors. Disease clusters belonging to the same ICD type (ﬁrst
letter of ICD code) are highlighted by colored patches in ﬁgure 4. Alternative visualizations of
the disease networks O are shown in the SI, ﬁgures S21–28, for each age group and gender. In
ﬁgures S21–28 we set pc = 0.02 and adjust ϕc such that each network has the same average
degree 〈 〉k .
3.3. Evolution of the human disease network across lifetime
We ﬁnd three distinct phases in the evolution of the diseases networks across lifetime.
Phase I. The disease network for children, phase I (age 0–16), shows one cluster
containing diseases of many different types, such as diseases of the respiratory system (letter J
Figure 3. Network properties for the disease network O. (A) number of nodes N, (B)
average degree 〈 〉k , (C) clustering coefﬁcients in units of Cr, and (D) average nearest
neighbor degrees 〈 〉k nn. O has the highest density for males and females aged 48–56.
Children are characterized by a higher density and higher clustering than teenagers.
There is a subsequent increase in N, 〈 〉k , and C Cr with age, up to a maximum value at
around age 50. The average degree of the nearest neighbors 〈 〉k nn increases also for
older ages. Error bars show the standard deviations.
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Figure 4. Evolution of the disease network for females (left) and males (right). Each
network corresponds to a snapshot at a given age, with age increasing from top to
bottom. Node sizes represent disease prevalences; the colors indicate the main
classiﬁcations of diseases according to the ﬁrst letter of the ICD 10 codes. The evolution
of the disease network proceeds in roughly three phases: phase I, childrenʼs diseases,
characterized by one large cluster and several small ones. Phase II, adult groups, in
which many different and clearly distinguishable clusters appear. Phase III, the network
for elderly patients, where the network becomes increasingly dominated by hubs.
Colored patches serve as guides to the eye for clusters of diseases belonging to the
same type.
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in the ICD code), infectious diseases (A), diseases of the eye and ear (H), and endocrine,
nutritional, and metabolic diseases (E). Highly prevalent are viral and other speciﬁed intestinal
infections (A08), diarrhea and gastroenteritis of presumed infectious origin (A09), chronic
diseases of tonsils and adenoids (J35), and non-suppurative otitis media (H65). These diseases
correspond to nodes that are characterized by large degrees and tend to be connected to each
other. There is a small cluster formed by diseases of the nervous system (G), with a local hub
being epilepsy (G40), and a cluster for mental and behavioral disorders (F). For male children
there is a cluster containing disorders of psychological development that is not visible for
females. For females in phase I there are small clusters containing diseases of the digestive
system (K) and of the genitourinary system (N), whereas for males phimosis and paraphimosis
(N47) belong to the main cluster. The network for young males is in general more dense than
for females in phase I, but the formation of disease clusters and the prevalences are similar. The
network for patients aged 8–16 is less dense than the network of the former age group, but the
same clusters are still visible (see SI ﬁgure S12). There are obvious changes, however, for the
next age group, 16–24, (see ﬁgure 4, second row), where the cluster for mental diseases (F)
dominates and contains more different nodes than in the previous networks. This can be seen as
the onset of the structural phase II of the disease networks.
Phase II. In phase II (age 16–64), a cluster of mental and behavioral disorders (F) appears
more clearly and contains addiction to nicotine, alcohol, and other substance abuses. It has a
higher density for women than for men. For both genders in the age group 16–24, the
prevalences of diseases are smaller than in phase I, but infections (A08 and A09), tonsil
problems (J35), and disorders of the prepuce for men (N47) are still highly prevalent. Children
and young patients suffer similarly from obesity (E66), which becomes increasingly prevalent
starting with patients aged 16–24y. Hypertension (I10) becomes also visible at this age, but it is
not yet a dominant disease.
At ages 32–40 the cluster of diseases of the digestive system (K) emerges for men (see
ﬁgure 4, third row). Hemorrhoids (I84) are found at the periphery of this cluster with links
exclusively to digestive diseases; there are no links from hemorrhoids to any other circulatory
disease. The cluster of diseases of the genitourinary system (N) exists still only for women and
grows with age. It is connected to benign neoplasms and blood diseases (D). For patients over
40, leiomyoma of the uterus (D25) are very common. This disease has many links to both
genitourinary disorders (N) and to malignant neoplasms (C), especially related to female genital
organs. The most prevalent neoplasms are breast cancer (C50) for women and prostate cancer
(C61) for men. Neoplasms are located at the periphery of the network and show many inter-
cluster connections, such as links to secondary neoplasms.
The cluster of circulatory diseases (I) appears for men older than 32 and women older than
40. It densiﬁes for older age groups. This cluster is also much denser for men than for women;
see ﬁgure 4, fourth row. Another gender difference for this age group is the absence of
genitourinary diseases (N) for men, while for women these diseases become increasingly
prevalent until the age of 40. The most common circulatory disease is hypertension (I10).
Already at age 40–48 it has a large number of links inside and outside the cluster of circulatory
diseases.
The origin of the cluster related to diseases of the musculoskeletal system (M) is visible for
both genders at age 24–32 (see SI ﬁgure S14); for older groups, this cluster becomes denser
more quickly for females than for males. This may be related to osteoporosis (M81), which is a
hub only for women over 48 and serves as a gateway to many musculoskeletal diseases. An
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important structural change begins at age 64, where some clusters start to shrink, such as mental
disorders (F) and genitourinary diseases (N) for women. This marks the beginning of phase III
(age 64–80) of the evolution of the disease network.
Phase III. A contraction of the network toward its center can be observed in ﬁgure 4,
bottom row, where it becomes increasingly dominated by circulatory (I) and metabolic (E)
diseases. Global hubs appear—in particular, hypertension (I10), depression (F32), ischemic
heart diseases (I25), chronic obstructive pulmonary disease (COPD, J44), the metabolic
syndrome including disorders of lipoprotein metabolism (E78), type 2 diabetes (E11), and
obesity (E66). There are also some local hubs—for example, cataracts (H25). Clearly
discernible clusters disappear in phase III, with the exception of musculoskeletal disorders (M)
for females. Neoplasms (C) become increasingly interconnected. The effect of the network
contraction progresses in the oldest groups (age 72–80), where it is even more difﬁcult to
distinguish speciﬁc clusters (see SI ﬁgure S19).
The three phases are also apparent in the evolution of the network properties of the disease
network; see ﬁgure 3. In phase I (childhood) we ﬁnd large clustering and degrees at a
comparably small network size N. This suggests a tightly interconnected cluster of diseases
spanning only a small part of the entire possible network. Phase II presents itself as a steady
increase in clustering and network density. This trend levels off once substantial parts of the
network show high levels of disease prevalences. In phase III clustering and density decrease,
whereas the average nearest neighbor degree increases. This suggests the emergence of hubs
that become connected to an increasing number of other diseases, whereas the local clusters that
characterize phase II disappear. On a more quantitative level, we ﬁtted the degree distributions
with q-exponentials [27, 28] and report the values of q for males and females across age groups
in ﬁgures S2–4 in the SI. In general, q increases over lifetime, but there is a prominent peak at
ages 16 and 24, indicating again a massive change of regime in network topology.
4. Network diffusion model of disease progression on the population level
It has been suggested that the spread of diseases may be related to a diffusion process on disease
networks [11]. Along these lines we propose a simple model that assumes that individuals can
acquire new diseases that are comorbidities of already existing ones. This is, of course, a crude
simpliﬁcation of the actual processes that lead to disease incidences.
Assume that the prevalence of disease i in males/females of age group a is
=p a( )im f
N a
N a
( )
( )
i
m f
m f
. Let the expected prevalence of disease i at the next age group be denoted by
+p aˆ ( 1)im f . We then make the simple network diffusion Ansatz,
∑Δ+ = + −
≠
( )p a p a p a P a p aˆ ( 1) ( ) 1 ( ) ( ) ( ), (5)im f im f im f
j i
ij
m f
j
m f
where Δ = + −P a P a P a( ) ( 1) ( )ijm f ijm f ijm f is the difference between the conditional disease
risks for age groups +a 1 and a. ΔP a( )ijm f is the risk of obtaining disease i given j for a patient
aging from age group a to +a 1. This number is multiplied with the probabilities to have
disease j and to not have disease i to give the disease network effect on the disease prevalences.
To estimate the quality of the model, we compute the correlation coefﬁcient ρ between the
actually observed prevalences at the next timestep, +p a( 1)im f , and the predicted result of
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equation (5), ρ = + +( )p a p acorr ˆ ( 1), ( 1)im f im f . The value of ρ quantiﬁes how much of the
variance of disease prevalences at a given age a can be explained by the prevalences of diseases
in the previous age group, superimposed by the risk from disease spreading from nearby nodes
in the disease network. The values for ρ for the network diffusion model (NDM) are shown in
ﬁgure 5(A) for women and ﬁgure 5(B) for men. The correlation coefﬁcients for the NDM are
higher than 90% for ages above 50. To estimate the importance of comorbidities in the NDM,
we compare its results with the correlation coefﬁcient obtained for a variant of the model in
equation (5), where we ignore the second term on the right-hand side; i.e., we ignore effects
from the disease network and set Δ =P 0ijm f . This variant we call the ‘baseline model.’ Results
are also collected in ﬁgure 5. These results suggest that a substantial fraction of disease
incidents can be predicted on the basis of the diseases that exist at the previous age group alone.
Clearly, the diffusion model consistently outperforms the baseline model for all ages and gender
groups. In the age range 40–80 the disease network effect increases the explanatory power
compared to the baseline model only by a couple of percentage points. Gender differences can
be observed. For women at age 48 the quality gap between the models is about 5%, compared
to 2–3% for men. This may be related to physiological changes during the menopause.
Important physiological changes also take place during puberty and adolescence. During these
ages the baseline model is able to explain up to 70% of the variance of disease prevalences,
whereas the NDM performs substantially better 85–90%.
5. Discussion
The health state of patients is typically characterized by multiple comorbid conditions,
especially among adults and the elderly. We proposed a phenotypic human disease network that
Figure 5. Correlation coefﬁcients ρ between actual prevalence data and predictions
from the network diffusion model (NDM) are shown for females (A) and males (B).
NDM results are compared to the baseline model without diffusion term. The disease
network effect (difference between lines) consistently increases correlations by up to
20%, especially for children and adolescents. The importance of diffusion diminishes
with higher ages.
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is derived from a multiplex network of two statistical measures quantifying relations between
diseases. This network contains information about which diseases are typically treated together
in a patient. We showed that the disease network undergoes dramatic structural transformations
as a function of patient age and gender. In particular, one can distinguish three phases in the
evolution of the disease network. The ﬁrst phase describes the comorbidity relations in children
and consists of a single, strongly interconnected cluster. The second phase for adolescents and
adults is characterized by the appearance of subsequent clusters related to speciﬁc classes of
diseases. For instance, clusters of mental disorders appear in both genders in younger adults,
whereas genitourinary disorders appear only for women. Clusters for circulatory, musculoske-
letal, and digestive diseases appear in subsequent life years. In the last phase, for elderly people
above 65, disease clusters condense and several highly connected hubs appear and dominate the
network. These hubs are hypertension, chronic ischemic heart diseases, and COPD.
Interestingly, it has been shown that several cardiac and respiratory functions undergo abrupt
changes at around age 65, where the transition from phase II to III occurs [29, 30]. The results
presented here allow us to understand developments in population health across life in a new
way. With the adoption of a network perspective, the focus shifts from the study of individual
disease progression to transformations of the mesoscopic organization of the disease network.
We showed that each stage of life can be characterized by its unique set of clusters of closely
interrelated diseases.
We developed a network diffusion model that shows that patients indeed develop new
diseases in close proximity in the disease network to disorders they already have. A thorough
topological understanding of disease–disease relations is therefore key to anticipating future
developments in population health. It is remarkable that the vast majority of new disease onsets
can be explained by the conditional disease risks P i j( | ) alone. Combined with models that
describe demographic changes in the age structure of a population, the network diffusion model
proposed in this work may provide an attractive starting point to predict future burdens of
diseases within an aging society.
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